Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Healthcare Policy

Dáil Éireann Debate, Tuesday - 12 July 2022

Tuesday, 12 July 2022

Ceisteanna (991)

Colm Burke

Ceist:

991. Deputy Colm Burke asked the Minister for Health the person within the HSE who decides if a product is experimental in respect of the treatment abroad scheme; the criteria that this decision maker uses to decide such and the definitions applied to experimental treatments; if the relevant decision makers have the expertise to review drugs for complex conditions; if the existing reimbursement list is referred to in making reimbursement decisions or whether European Medicines Agency approval is deemed to be the overriding proof of clinical safety; and if he will make a statement on the matter. [37831/22]

Amharc ar fhreagra

Freagraí scríofa

As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Question No. 992 answered with Question No. 976.
Question No. 993 answered with Question No. 976.
Barr
Roinn